MedTrace Logo

Right Ventricular Function During Liver Transplantation as Assessed by Transesophageal Echocardiography.

NCT03459924 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-03-09

No results posted yet for this study

Summary

Cirrhotic patients undergoing liver transplantation might develop acute transient right ventricular dysfunction, ranging from mild to severe form. More than two decades ago, a number of studies with pulmonary artery catheters looked at this particular issue with controversial results. However, the pulmonary artery catheter as a monitor for right ventricular function (RVF) has several limitations, while the echocardiogram is deemed to be more accurate in this regard. Therefore, we sought to evaluate the RVF with the transesophageal echocardiogram, and particularly whether the RVF significantly varies during this procedure.

Conditions

  • Liver Transplant; Complications

Sponsors & Collaborators

Principal Investigators

  • Nubia V Figueiredo, MSc, PhD · Universidade Federal do Rio de Janeiro

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-27
Primary Completion
2019-01-01
Completion
2019-01-01

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03459924 on ClinicalTrials.gov